1. Executive Summary
1.1. Global Mammalian Cell Banking Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Mammalian Cell Banking Market Outlook, 2018 - 2031
3.1. Global Mammalian Cell Banking Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. CHO
3.1.1.2. BHK
3.1.1.3. NS0
3.1.1.4. YB2/0 & P2/0
3.1.1.5. HEK293 & Derivatives
3.1.1.6. HELA
3.2. Global Mammalian Cell Banking Market Outlook, by Technology, Value (US$ Mn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. TEP
3.2.1.2. IEP
3.2.1.3. SEP
3.3. Global Mammalian Cell Banking Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. MCB
3.3.1.2. WCB
3.3.1.3. EoP
3.3.1.4. R&D CB
3.4. Global Mammalian Cell Banking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Academic & Research Institute
3.4.1.2. Biopharmaceutical Companies
3.4.1.3. CROs
3.5. Global Mammalian Cell Banking Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Mammalian Cell Banking Market Outlook, 2018 - 2031
4.1. North America Mammalian Cell Banking Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. CHO
4.1.1.2. BHK
4.1.1.3. NS0
4.1.1.4. YB2/0 & P2/0
4.1.1.5. HEK293 & Derivatives
4.1.1.6. HELA
4.2. North America Mammalian Cell Banking Market Outlook, by Technology, Value (US$ Mn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. TEP
4.2.1.2. IEP
4.2.1.3. SEP
4.3. North America Mammalian Cell Banking Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. MCB
4.3.1.2. WCB
4.3.1.3. EoP
4.3.1.4. R&D CB
4.4. North America Mammalian Cell Banking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Academic & Research Institute
4.4.1.2. Biopharmaceutical Companies
4.4.1.3. CROs
4.5. North America Mammalian Cell Banking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
4.5.1.2. U.S. Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
4.5.1.3. U.S. Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
4.5.1.4. U.S. Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
4.5.1.5. Canada Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
4.5.1.6. Canada Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
4.5.1.7. Canada Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
4.5.1.8. Canada Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Mammalian Cell Banking Market Outlook, 2018 - 2031
5.1. Europe Mammalian Cell Banking Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. CHO
5.1.1.2. BHK
5.1.1.3. NS0
5.1.1.4. YB2/0 & P2/0
5.1.1.5. HEK293 & Derivatives
5.1.1.6. HELA
5.2. Europe Mammalian Cell Banking Market Outlook, by Technology, Value (US$ Mn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. TEP
5.2.1.2. IEP
5.2.1.3. SEP
5.3. Europe Mammalian Cell Banking Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. MCB
5.3.1.2. WCB
5.3.1.3. EoP
5.3.1.4. R&D CB
5.4. Europe Mammalian Cell Banking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Academic & Research Institute
5.4.1.2. Biopharmaceutical Companies
5.4.1.3. CROs
5.5. Europe Mammalian Cell Banking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Germany Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
5.5.1.2. Germany Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
5.5.1.3. Germany Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
5.5.1.4. Germany Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
5.5.1.5. U.K. Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
5.5.1.6. U.K. Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
5.5.1.7. U.K. Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
5.5.1.8. U.K. Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
5.5.1.9. France Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
5.5.1.10. France Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
5.5.1.11. France Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
5.5.1.12. France Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
5.5.1.13. Italy Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
5.5.1.14. Italy Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
5.5.1.15. Italy Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
5.5.1.16. Italy Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
5.5.1.17. Turkey Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
5.5.1.18. Turkey Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
5.5.1.19. Turkey Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
5.5.1.20. Turkey Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
5.5.1.21. Russia Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
5.5.1.22. Russia Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
5.5.1.23. Russia Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
5.5.1.24. Russia Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
5.5.1.25. Rest of Europe Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
5.5.1.26. Rest of Europe Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
5.5.1.27. Rest of Europe Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
5.5.1.28. Rest of Europe Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Mammalian Cell Banking Market Outlook, 2018 - 2031
6.1. Asia Pacific Mammalian Cell Banking Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. CHO
6.1.1.2. BHK
6.1.1.3. NS0
6.1.1.4. YB2/0 & P2/0
6.1.1.5. HEK293 & Derivatives
6.1.1.6. HELA
6.2. Asia Pacific Mammalian Cell Banking Market Outlook, by Technology, Value (US$ Mn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. TEP
6.2.1.2. IEP
6.2.1.3. SEP
6.3. Asia Pacific Mammalian Cell Banking Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. MCB
6.3.1.2. WCB
6.3.1.3. EoP
6.3.1.4. R&D CB
6.4. Asia Pacific Mammalian Cell Banking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Academic & Research Institute
6.4.1.2. Biopharmaceutical Companies
6.4.1.3. CROs
6.5. Asia Pacific Mammalian Cell Banking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. China Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
6.5.1.2. China Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
6.5.1.3. China Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
6.5.1.4. China Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
6.5.1.5. Japan Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
6.5.1.6. Japan Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
6.5.1.7. Japan Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
6.5.1.8. Japan Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
6.5.1.9. South Korea Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
6.5.1.10. South Korea Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
6.5.1.11. South Korea Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
6.5.1.12. South Korea Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
6.5.1.13. India Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
6.5.1.14. India Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
6.5.1.15. India Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
6.5.1.16. India Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
6.5.1.17. Southeast Asia Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
6.5.1.18. Southeast Asia Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
6.5.1.19. Southeast Asia Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
6.5.1.20. Southeast Asia Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
6.5.1.21. Rest of Asia Pacific Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
6.5.1.22. Rest of Asia Pacific Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
6.5.1.23. Rest of Asia Pacific Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
6.5.1.24. Rest of Asia Pacific Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Mammalian Cell Banking Market Outlook, 2018 - 2031
7.1. Latin America Mammalian Cell Banking Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. CHO
7.1.1.2. BHK
7.1.1.3. NS0
7.1.1.4. YB2/0 & P2/0
7.1.1.5. HEK293 & Derivatives
7.1.1.6. HELA
7.2. Latin America Mammalian Cell Banking Market Outlook, by Technology, Value (US$ Mn), 2018 - 2031
7.2.1.1. TEP
7.2.1.2. IEP
7.2.1.3. SEP
7.3. Latin America Mammalian Cell Banking Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. MCB
7.3.1.2. WCB
7.3.1.3. EoP
7.3.1.4. R&D CB
7.4. Latin America Mammalian Cell Banking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Academic & Research Institute
7.4.1.2. Biopharmaceutical Companies
7.4.1.3. CROs
7.5. Latin America Mammalian Cell Banking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Brazil Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
7.5.1.2. Brazil Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
7.5.1.3. Brazil Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
7.5.1.4. Brazil Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
7.5.1.5. Mexico Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
7.5.1.6. Mexico Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
7.5.1.7. Mexico Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
7.5.1.8. Mexico Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
7.5.1.9. Argentina Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
7.5.1.10. Argentina Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
7.5.1.11. Argentina Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
7.5.1.12. Argentina Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
7.5.1.13. Rest of Latin America Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
7.5.1.14. Rest of Latin America Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
7.5.1.15. Rest of Latin America Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
7.5.1.16. Rest of Latin America Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Mammalian Cell Banking Market Outlook, 2018 - 2031
8.1. Middle East & Africa Mammalian Cell Banking Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. CHO
8.1.1.2. BHK
8.1.1.3. NS0
8.1.1.4. YB2/0 & P2/0
8.1.1.5. HEK293 & Derivatives
8.1.1.6. HELA
8.2. Middle East & Africa Mammalian Cell Banking Market Outlook, by Technology, Value (US$ Mn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. TEP
8.2.1.2. IEP
8.2.1.3. SEP
8.3. Middle East & Africa Mammalian Cell Banking Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. MCB
8.3.1.2. WCB
8.3.1.3. EoP
8.3.1.4. R&D CB
8.4. Middle East & Africa Mammalian Cell Banking Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Academic & Research Institute
8.4.1.2. Biopharmaceutical Companies
8.4.1.3. CROs
8.5. Middle East & Africa Mammalian Cell Banking Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. GCC Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
8.5.1.2. GCC Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
8.5.1.3. GCC Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
8.5.1.4. GCC Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
8.5.1.5. South Africa Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
8.5.1.6. South Africa Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
8.5.1.7. South Africa Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
8.5.1.8. South Africa Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
8.5.1.9. Egypt Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
8.5.1.10. Egypt Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
8.5.1.11. Egypt Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
8.5.1.12. Egypt Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
8.5.1.13. Nigeria Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
8.5.1.14. Nigeria Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
8.5.1.15. Nigeria Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
8.5.1.16. Nigeria Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
8.5.1.17. Rest of Middle East & Africa Mammalian Cell Banking Market by Cell Type, Value (US$ Mn), 2018 - 2031
8.5.1.18. Rest of Middle East & Africa Mammalian Cell Banking Market By Technology, Value (US$ Mn), 2018 - 2031
8.5.1.19. Rest of Middle East & Africa Mammalian Cell Banking Market By Application, Value (US$ Mn), 2018 - 2031
8.5.1.20. Rest of Middle East & Africa Mammalian Cell Banking Market End User, Value (US$ Mn), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Application vs By Technology Heatmap
9.2. Manufacturer vs By Technology Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Eurofins DiscoverX Corporation
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Merck KGaA
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Sartorius Stedim BioOutsource Limited.
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Charles River Laboratories
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Altogen Labs
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Abzena Ltd
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Northway Biotechpharma
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Lonza Group Ltd
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. VIRUSURE
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Selexis SA
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Takara Bio Inc
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations